Could oxidative stress associate with age products in cataractogenesis?

Current Eye Research

Volumn 33, Issue 8, 2008, Pages 669-675

  Gul, Anjuman ^a   Rahman, M Ataur ^b   Hasnain, Syed Nazurl ^a   Salim, Asmat ^b   Simjee, Shabana U ^b  

^a ZIAUDDIN UNIVERSITY   (Pakistan)

^b UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Advanced glycation end products; Cataract; Diabetes; Malondialdehyde; Oxidative stress; Vitamin E

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MALONALDEHYDE;

ADULT; AGED; AGING; ARTICLE; CATARACT; CATARACTOGENESIS; CONTROLLED STUDY; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; CATARACT; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; VITAMIN E;

EID: 49549101810     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680802250939     Document Type: Article

References (35)

1. Shah SP, Dineen B, Jadoon Z, Bourne R, Khan MA, Johnson GJ, De Stavola B, Gilbert C, Khan MD. Lens opacities in adults in Pakistan: Prevalence and risk factors. Ophthalmic Epidemiol. 2007;14:381-389.
2. Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res. 2001;56:1-1.
3. Bron AJ, Brown NAP, Harding JJ, Ganea E. The lens and cataract in diabetes. Int Ophthalmol Clin. 1998;38:37-37.
4. Taylor A, Jacques PF, Epstein EM. Relations among aging, antioxidant status, and cataract. Am J Clin Nutr. 1995;62:1439S-1447S.
5. Kasper M, Funk RHW. Age-related changes in cells and tissues due to advanced glycation end products (AGEs). Arch Gerontol Geriatr. 2001;32:233-243.
6. Ahmed N. Advanced glycation end products' role in pathology of diabetic complications. Diab Res Clin Pract. 2005;67:3-21.
7. Lee AY, Chung SS. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 1999;13:23-30.
8. Spector A. Oxidative stress-induced cataract: Mechanism of action. FASEB J. 1995;9:1173-1182.
9. Valenzuela A. The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress. Life Sci. 1991;48:301-309.
10. Hashim Z, Zarina S. Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract. Clin Biochem. 2007;40:705-709.
11. Maurya OP, Mohanty L, Bhaduri G, Chandra A. Role of anti-oxidant enzymes superoxide dismutase and catalase in the development of cataract: Study of serum levels in patients with senile and diabetic cataracts. J Indian Med Assoc. 2006;104:396-397.
12. Gabir MM, Roumain J, Hanson RL, Bennett PH, Dabelea D, Knowler WC, Imperatore G. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diab Care. 2000;23:1108-1112.
13. Baker H, Frank O, Angelis B, Feingold S. Plasma tocopherol in man at various times after ingesting free or acetylated tocopherol. Nutr Rep Int. 1980;21:531-536.
14. Ono Y, Aoki S, Ohnishi K, Yasuda T, Kawano K, Tsukada Y. Increased serum levels of advanced glycation end products and diabetic complications. Diab Res Clin Pract. 1998;41:131-137.
15. Shera S. Prevalence and prevention. Diab Digest. 1998;12:7-8.
16. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diab Care. 1996;19:257-267.
17. Kravchuk EA. Free-radical oxidation in the pathogenesis of eye diseases. Vestn Oftalmol. 2004;120:48-51.
18. Suji G, Sivakami S. Glucose, glycation, and aging. Biogerontology. 2004;5:365-373.
19. Doelman CJ. Lens lipid peroxides in diabetic cataract. Ann Clin Biochem. 1997;34:700-706.
20. Donma O, Yorulmaz E, Pekel H, Suyugül N. Blood and lens lipid peroxidation and antioxidant status in normal individuals, senile, and diabetic cataractous patients. Curr Eye Res. 2002;25:9-16.
21. Agte VV, Tarwadi KV. Combination of diabetes and cataract worsens the oxidative stress and micronutrient status in Indians. Nutrition. 2008;8 (in press).
22. Zoríc L. Parameters of oxidative stress in the lens, aqueous humor, and blood in patients with diabetes and senile cataracts. Srp Arh Celok Lek. 2003;131:137-142.
23. Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem. 1992;267:10211-10214.
24. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation end products: Biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest. 1994;70:138-151.
25. Turk Z, Miŝur I, Turk N. Temporal association between lens protein glycation and cataract development in diabetic rats. Acta Diabetol. 1997;34:49-54.
26. Zarina S, Zhao HR, Abraham EC. Advanced glycation end products in human senile and diabetic cataractous lenses. Mol Cell Biochem. 2000;210:29-34.
27. Luthra M, Balasubramania D. Nonenzymatic glycation alters protein structure and stability. A study of two eye lens crystallins. J Biol Chem. 1993;268:18119-18127.
28. Nagaraj RH, Sell DR, Prabhakaram M, Ortwerth BJ, Monnier VM. High correlation between pentosidine protein cross links and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. Proc Natl Acad Sci USA. 1992;88:10257-10261.
29. Stitt AW. Advanced glycation: An important pathological event in diabetic and age-related ocular disease. Br J Ophthalmol. 2001;85:746-753.
30. Tan KC, Shiu SW, Chow WS, Leng L, Bucala R, Betteridge DJ. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes. Diabetologia. 2006;49:2756-2762.
31. Yamagishi S, Adachi H, Nakamura K, Matsui T, Jinnouchi Y, Takenaka K, Takeuchi M, Enomoto M, Furuki K, Hino A, Shigeto Y, Imaizumi T. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects. Metabolism. 2006;55:1227-1231.
32. Sisková A, Wilhelm J. Role of nonenzymatic glycation and oxidative stress on the development of complicated diabetic cataracts. Cesk Fysiol. 2000;49:16-21.
33. Dyer DG, Blackledge, JA, Thorpe SR, Baynes JW. Formation of pentosidine during nonenzymatic browning of protein by glucose: Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem. 1991;266:11654-11660.
34. Jono T, Nagai R, Lin X, Ahmed N, Thornalley PJ, Takeya M, Horiuchi S. Nepsilon-(carboxymethyl)lysine and 3-DG-imidazolone are major AGE structures in protein modification by 3-deoxyglucosone. J Biochem. 2004;136:351-358.
35. Cai W, Cao Q, Zhu L, Peppa M, He C, Vlassara H. Oxidative stress-inducing carbonyl compounds from common foods: Novel mediators of cellular dysfunction. Mol Med. 2002;8:337-346.